Peptinov

Developer of anti-cytokine immunotherapies for the treatment of chronic inflammatory diseases

placeParis, Ile De France, France calendar_todayFounded 2010 groups8 employees language peptinov.fr

Innovation

11 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace steady. Cited 260 times.

YearFilings
20131
20141
20161
20172
20181
20193
20214
20224
20234
20243
20255
20262

Social engagement

Social engagement: 1.8K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include EIC Fund.

Investor typeCountShare
Accelerator & incubator1100%

Recent activity

13 Jan 2026
Event
J.P. Morgan Healthcare Conference 2026
6 Nov 2025
Milestone
regulatory
Coming soon